Initial experience of magnetic seed localization for impalpable breast lesion excision: First 100 cases performed in a single Irish tertiary referral centre.
Murphy E, Quinn E, Stokes M, Kell M, Barry M, Flanagan F, Walsh SM.
Surgeon. 2022 Jun;20(3):e36-e42. doi: 10.1016/j.surge.2021.02.010. Epub 2021 Apr 8.
Intact Excision of Breast Lesions Using BLES: Is There a Clinical Indication Yet?
Yao K.
Ann Surg Oncol. 2019 Apr;26(4):933-935. doi: 10.1245/s10434-019-07214-0. Epub 2019 Feb 8.
Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas.
Björnström M, Niinikoski L, Meretoja TJ, Leidenius MHK, Hukkinen K.
Eur J Surg Oncol. 2022 Jan;48(1):67-72. doi: 10.1016/j.ejso.2021.10.020. Epub 2021 Oct 27.
Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study.
Niinikoski L, Hukkinen K, Leidenius MHK, Ståhls A, Meretoja TJ.
Eur J Surg Oncol. 2018 Jan;44(1):59-66. doi: 10.1016/j.ejso.2017.10.213. Epub 2017 Nov 14.
Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study.
Mann GB, Skandarajah AR, Zdenkowski N, Hughes J, Park A, Petrie D, Saxby K, Grimmond SM, Murugasu A, Spillane AJ, Chua BH, Badger H, Braggett H, Gebski V, Mou A, Collins JP, Rose AK.
Lancet. 2024 Jan 20;403(10423):261-270. doi: 10.1016/S0140-6736(23)02476-5. Epub 2023 Dec 5.
Resection of primary lesion for patients with metastatic breast cancer: where are we now?
Hu Q, Zhong X, Liu X, Xie Y, Hu K, He P, Lu D, Zheng H.
Chin Clin Oncol. 2018 Jun;7(3):24. doi: 10.21037/cco.2018.05.03.
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S.
Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.
SAVI Scout System for Excision of Non-Palpable Breast Lesions.
Farha MJ, Simons J, Kfouri J, Townsend-Day M.
Am Surg. 2023 Jun;89(6):2434-2438. doi: 10.1177/00031348221096576. Epub 2022 May 4.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01.
Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5.
Cosmetic outcomes following wide local excision of impalpable breast cancer: is radioguided occult lesion localization using iodine-125 seeds better than hookwire localization?
Preuss J, Nezich R, Lester L, Poh S, Saunders C, Taylor D.
ANZ J Surg. 2021 Sep;91(9):1759-1765. doi: 10.1111/ans.16756. Epub 2021 Apr 12.
